Press "esc" to clear
Go to Advanced Search
Showing results 1120 of 2659

Article ID: 700826

Morehouse School of Medicine Awarded $200,000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials

Clinical Research Pathways

Under the three-year program, minority physicians will be recruited to conduct clinical trials—research studies that prospectively assign human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. The goal is to encourage more minority patients to participate in clinical trials by taking trials directly to minority patient populations.

20-Sep-2018 12:00 PM EDT

Article ID: 700834

Moving Homegrown Ideas into the Clinic

University of Kansas Cancer Center

Physician-scientists at The University of Kansas Cancer center are designing and initiating their own clinical trials.

20-Sep-2018 11:05 AM EDT
  • Embargo expired:
    20-Sep-2018 11:00 AM EDT

Article ID: 700693

Octopuses Given Mood Drug ‘Ecstasy’ Reveal Genetic Link to Evolution of Social Behaviors in Humans

Johns Hopkins Medicine

By studying the genome of a kind of octopus not known for its friendliness toward its peers, then testing its behavioral reaction to a popular mood-altering drug called MDMA or “ecstasy,” scientists say they have found preliminary evidence of an evolutionary link between the social behaviors of the sea creature and humans, species separated by 500 million years on the evolutionary tree.

18-Sep-2018 10:00 AM EDT

Social and Behavioral Sciences

Article ID: 700816

MyoKardia Launches Inaugural MyoSeeds™ Research Grants Program to Advance Independent Research in Heart Disease


MyoKardia, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced the launch of the MyoSeeds™ Research Grants Program, a new initiative to support original, independent research in the biology and underlying mechanisms of cardiomyopathies and precision heart disease treatment with the goal of improving the lives of patients.

20-Sep-2018 8:05 AM EDT

Article ID: 700782

Newborn Opioid Withdrawal Requires a 'Cascade of Care,' Study Suggests

Wolters Kluwer Health: Lippincott Williams and Wilkins

Effective management of neonatal abstinence syndrome (NAS) – withdrawal symptoms occurring in infants exposed to opioids in utero – requires a coordinated "cascade of care" from prevention through long-term follow-up, reports a study in Advances in Neonatal Care, official journal of the National Association of Neonatal Nurses. The journal is published in the Lippincott portfolio by Wolters Kluwer.

19-Sep-2018 11:05 AM EDT

Article ID: 700777

Summit on Drug Shortages to Examine Impact on National Security and Health Care Infrastructure

American Society of Anesthesiologists (ASA)

On September 20, a coalition of health care leaders will host a summit, “Drug Shortages as a Matter of National Security: Improving the Resilience of the Nation’s Health Care Critical Infrastructure.” The meeting will examine vulnerabilities in the supply chain, U.S. dependence on foreign-sourced pharmaceutical ingredients, disaster planning and response efforts, and risk factors associated with pharmaceutical manufacturing and distribution.

19-Sep-2018 10:05 AM EDT

Article ID: 700730

How Cells Repurpose their Garbage Disposal Systems to Promote Inflammation

University of California San Diego Health

Researchers at University of California San Diego School of Medicine have unraveled new insights into the way cells leverage G-protein-coupled receptors (GPCRs) and their cellular waste disposal systems to control inflammation. The findings, published September 18 in Cell Reports, suggest some existing cancer drugs that inhibit these cellular activities might be repurposed to treat vascular inflammation, which occurs when artery-blocking plaques form in atherosclerosis.

18-Sep-2018 1:05 PM EDT

Article ID: 700702

New Online Educational Series Offers Instruction in Safe and Effective Prescribing

PhRMA Foundation

The PhRMA Foundation announced today the launch of a new online educational series for medical, nursing and pharmacy schools on safe and effective prescribing, featuring instruction from national experts.

18-Sep-2018 10:05 AM EDT

Article ID: 700703

Study to Examine Possible Effects of Cannabis Compound for Common Movement Disorder

University of California San Diego Health

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor (ET). Currently, ET is treated using repurposed medications originally developed for high blood pressure or seizures.

18-Sep-2018 10:05 AM EDT

Showing results 1120 of 2659

Chat now!